Dear Colleagues, Welcome to FICARE 2024!
It is our pleasure to announce that from November 14th to 15th São Paulo will be stage of the largest forum on Rectal Cancer in Latin America. FICARE 2024 will take place in the WTC Sheraton Hotel in São Paulo, Brazil!
Once again we are bringing together a stellar group of faculty in a very intense 2-day meeting to cover the latest and the most exciting of rectal cancer data worldwide!
The very best knowledge creators worldwide will debate, here, on TNT advancements and how to select patients for each strategy. Is there still role for straight forward surgery in the post-pandemic era? What about local excision for rectal cancer, is it the past or is it the future? All together in this very exciting meeting. From improvements in surgical technique, to refined selection for organ preservation. From enhanced radiological staging, to personalized onco-radiation therapies. You cannot miss it.
Get ready for hot debates among outstanding world specialists in each topic.
We will have a blend of celebrities of rectal cancer such as Debora Schrag, Gina Brown, Roel Hompes; Quentin Denost, Emmanouil Fokas, Geerard Beets, Antonino Spinelli, Julio Garcia Aguilar, Andrea Cercek, Simon Bach, Sergey Efetov, Sun Myint, Gyuseog Choi and many others, the sessions will be extremely interesting.
Get ready for days of intense scientific activity, mixed with pleasant social activities and the opportunity to see friends and international guests again.
Welcome and enjoy!
Angelita Habr-Gama
President
Rodrigo Oliva Perez
General Secretary
Don't miss the World's Largest Rectal Cancer Forum
WTC Sheraton São Paulo Hotel
Av. das Nações Unidas, nº 12.559
Brooklin Novo
São Paulo – SP
08:00
08:10
Is Magnetic resonance useful to select patients for local treatment in early rectal cancer?
Gina Brown
When transanal Local excision for pT1 ALONE is enough? Preliminary data from the TESAR trial & intermuscular dissection.
Roel Hompes
Chemotherapy and Local Excision for early rectal cancers? The NEO trial.
Carl Brown
GRECCAR 12 – The use of neoadjuvant Folfirinox for organ-preservation.
Quentin Denost
Local excision after nCRT or TNT? When and how?
Julio Garcia Aguilar
Discussion
Intermuscular Local excision for early rectal cancer.
Roel Hompes
Completion TME after initial local excision – is it a nightmare?
Quentin Denost
Discussion
10:00
Total Neoadjuvant Therapy for the achievement of a cCR?
Guilherme Pagin São Julião
Short-course or Long-course when WW is the goal? The German trial and current data available.
Emmanouil Fokas
Long-course RT + Contact radiation leads nearly 90% organ preservation – Why anything else?
Sun Myint
Isn’t TME (without RT or chemotherapy) a better option?
Roel Hompes
Discussion
The anatomical landmarks and challenges for each compartment in pelvic exenteration.
Gina Brown
Level of sacral resection – what are the limits?
Quentin Denost
The recurrent lateral pelvic node long after TME.
Tsuyoshi Konishi
Discussion
13:00
PRODIGE – Why FOLFIRINOX should be the new normal in all locally advanced rectal cancer.
Thierry Conroy
PROSPECT – Can we avoid radiation? When and for whom can we eliminate RT?
Debora Schrag
OPRA - Is organ-preservation main-stream now? What still needs to be done? Lessons learned from the OPRA trial.
Julio Garcia-Aguilar
Current status of MSI rectal cancer managed by immunotherapy – Where are we at?
Andrea Cercek
Elderly and Frail patients with locally advanced disease – How to balance treatment morbidity.
Emmanouil Fokas
Discussion
15:30
Emmanouil Fokas
Debora Schrag
Julio Garcia-Aguilar
Thierry Conroy
Sun Myint
Gina Brown
Roel Hompes
Andrea Cercek
Radiological Assessment - How nodal staging became less relevant than other radiological features for the decision management in rectal cancer?
Gina Brown
MR quality in rectal cancer – How heterogenous is the quality of MR and how it impacts decision management?
Cinthia Ortega
How tridimensional vascular reconstruction may help surgeon plan/perform rectal cancer surgery.
Patricia Tejedor
What about lateral pelvic nodes? Pre or post treatment findings to consider lateral node dissection?
Tsuyoshi Konishi
Discussion
18:15
Retroperitonial approach for the left colon – When you do not want to get into the abdomen.
Sergey Efetov
Lateral node dissection – the role of ICG.
Gyu-Seog Choi
What is a proper D3 dissection in upper rectal cancer.
Sergey Efetov
Robotic TME – How I do it – step by step.
Laura Fernandez
Combined TME & prostatectomy with the use of robot.
Gyu-Seog Choi
Discussion
The “perfect” lateral node dissection with the robot – Tips and tricks.
Gyu-Seog Choi
Lateral node in the setting of a complete clinical response.
Guilherme Pagin São Julião
Lateral node dissection without preoperative treatment – Is there a role? What to do with a patient with a 7mm node in the absence of other high-risk factors?
Tsuyoshi Konishi
Discussion
10:00
When double-stapling is the preferred strategy and new stapling alternatives.
Bruna Vailati
Transrectal transection and single-stapled anastomosis x Pull-through – Choosing one or the other?
Quentin Denost
Diversion or no diversion – Who should not be diverted and why?
Roel Hompes
Why ICG SHOULD be implemented into routine clinical practice.
Quentin Denost
Partial mesorectal excision – It’s all about the level of transection.
Roel Hompes
Discussion
12:00
What happens when mrEMVI+ become ymrEMVI-?
Gina Brown
What is a near-complete clinical response and how to deal with it?
Julio Garcia Aguilar
Local regrowths & the risk of distant metastasis – are we really at risk?
Laura Fernandez
Discussion
Case Discussion in locally advanced rectal cancer
5 cases and 5 initial treatment strategies
Moderator: Rodrigo Perez and Fernanda Mazzucato
Emmanouil Fokas
Debora Schrag
Julio Garcia-Aguilar
Thierry Conroy
Sun Myint
Gina Brown
1. T4aN0
2. T2/T3aN1 CRM clear / intersphincteric plane clear
3. T4bN0 candidate for APR
4. T2N0 CRM clear / interphincteric plane clear
5. EMVI+ CRM clear / intersphincteric plane clear
15:30
Robotic TME with synchronous liver metastasis resection.
Patricia Tejedor
Management of anastomotic leaks – aggressive transanal approach.
Roel Hompes
Minimally invasive para-aortic nodal dissection.
Tsuyoshi Konish
Intraoperative bleeding during lateral pelvic node dissection.
Tsuyoshi Konish
Minimally invasive Deloyers Procedure.
Leonardo Corbi
Discussion
Is there a place for Immunotherapy in MSS rectal cancer?
Andrea Cercek
Can we increase organ-preservation by intensifying treatment? JANUS trial.
Josh Smith
ctDNA in rectal cancer – what is the role in adjuvant chemotherapy decision management? Can we extrapolate data from colon cancer?
Andrea Cercek
Discussion
Hotels Ficare 2024